LY
Lyka Labs Limited
LYKALABS.NS · NSE
₹82.90 -1.54% (-₹1.30)
1M +24.29%
Market Cap ₹3.01B
P/E Ratio -
Div. Yield -
ROE 8.93%
Bulios Fair Price
₹52.62
36.5% downside
Trenutna cena
₹82.9
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica LYKALABS.NS trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
30 /100
Expensive P/B 3.25x
P/FCF 58.40x
P/S 2.18x
Growth
81 /100
Growing Book val. growth 26.69%
Rev. growth 11.89%
FCF growth N/A
Profitability
16 /100
Weak FCF margin 3.74%
Op. margin 8.10%
Gross margin 22.63%
Quality
10 /100
Poor Asset turnover 0.79x
ROA 5.10%
ROIC 6.39%
Debt
48 /100
Moderate Current ratio 1.17x
Int. coverage -2.68x
Debt/Equity 0.53x
Stability
29 /100
Unstable Profitable years 0
EPS volatility 312.45%
Beta 0.41x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o LYKALABS.NS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Kunal Narendra Gandhi
Employees
648
Headquarters
Mumbai